Suppr超能文献

硝苯地平与坦索罗辛治疗输尿管下段结石的疗效比较

Nifedipine versus tamsulosin for the management of lower ureteral stones.

作者信息

Porpiglia Francesco, Ghignone Gianpaolo, Fiori Cristian, Fontana Dario, Scarpa Roberto Mario

机构信息

Division of Urology, Department of Clinical and Biological Sciences, University of Turin, San Luigi Hospital, Orbassano, Italy.

出版信息

J Urol. 2004 Aug;172(2):568-71. doi: 10.1097/01.ju.0000132390.61756.ff.

Abstract

PURPOSE

We evaluate and compare the effectiveness of 2 different medical therapies during watchful waiting in patients with lower ureteral stones.

MATERIALS AND METHODS

A total of 86 patients with stones less than 1 cm located in the lower ureter (juxtavesical or intramural tract) were enrolled in the study and were randomly divided into 3 groups. Group 1 (30) and 2 (28) patients received daily oral treatment of 30 mg deflazacort, (maximum 10 days). In addition group 1 patients received 30 mg nifedipine slow-release (maximum 28 days) and group 2 received 1 daily oral therapy of 0.4 mg tamsulosin (maximum 28 days), Group 3 patients (28) were used as controls. Statistical analyses were performed using Student's test, ANOVA test, chi-square test and Fisher's exact test.

RESULTS

The average stone size for groups 1 to 3 was 4.7, 5.42 and 5.35 mm, respectively, which was not statistically significant. Expulsion was observed in 24 of 30 patients in group 1 (80%), 24 of 28 in group 2 (85%) and 12 of 28 in group 3 (43%). The difference in groups 1 and 2 with respect to group 3 was significant. Average expulsion time for groups 1 to 3 was 9.3, 7.7 and 12 days, respectively. A statistically significant difference was noted between groups 2 and 3. Mean sodium diclofenac dosage per patient in groups 1 to 3 was 19.5, 26, and 105 mg, respectively. A statistical significant difference was observed between groups 1 and 2 with respect to group 3.

CONCLUSIONS

Medical treatments with nifedipine and tamsulosin proved to be safe and effective as demonstrated by the increased stone expulsion rate and reduced need for analgesic therapy. Moreover medical therapy, particularly in regard to tamsulosin, reduced expulsion time.

摘要

目的

我们评估并比较两种不同药物治疗对输尿管下段结石患者观察等待期间的疗效。

材料与方法

总共86例输尿管下段(膀胱壁段或壁内段)结石小于1 cm的患者纳入本研究,并随机分为3组。第1组(30例)和第2组(28例)患者每日口服30 mg去氟可特(最长10天)。此外,第1组患者服用30 mg缓释硝苯地平(最长28天),第2组患者每日口服0.4 mg坦索罗辛(最长28天),第3组患者(28例)作为对照。采用学生检验、方差分析、卡方检验和费舍尔精确检验进行统计学分析。

结果

第1至3组结石平均大小分别为4.7、5.42和5.35 mm,差异无统计学意义。第1组30例患者中有24例(80%)结石排出,第2组28例中有24例(85%),第3组28例中有12例(43%)。第1组和第2组与第3组相比差异有统计学意义。第1至3组结石平均排出时间分别为9.3、7.7和12天。第2组和第3组之间差异有统计学意义。第1至3组患者双氯芬酸钠平均剂量分别为19.5、26和105 mg。第1组和第2组与第3组相比差异有统计学意义。

结论

硝苯地平和坦索罗辛药物治疗经结石排出率增加和镇痛治疗需求减少证明是安全有效的。此外,药物治疗,尤其是坦索罗辛,缩短了排出时间。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验